Action
Category includes all drugs used for treatment of depression.

Status
Agents are indicated for treatment of major depression and other psychiatric disorders. Trials are underway to evaluate antidepressant medication for use in post-stroke depression and stroke recovery.

Trial(s)
  = Ongoing
  = Completed

	AIM	AIM: A Randomized Trial of Treatment for Post-Stroke Depression
		Antidepressant Therapy After Stroke
		Central Nervous System Serotonin Blockage in Acute Cerebral Infarction
		Citalopram for post-stroke pathological crying
		Combined treatment with imipramine or desipramine and mianserin for poststroke depression
		Controlled trial of amitriptyline and carbamazepine for central poststroke pain
		Effects of Fluoxetine and Maprotiline on Functional Recovery in Poststroke Hemiplegic Patients Undergoing Rehabilitation Therapy
		Fluoxetine in Early Poststroke Depression
		Nortriptyline Versus Fluoxetine in the Treatment of Depression and in Short-Term Recovery After Stroke
		Sertraline in stroke-associated lability of mood
		Treatment of Poststroke Depression with Citalopram

UID: 166